# Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

> **NCT07436845** · — · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Emotional Distress
- HAIC(Hepatic Artery Infusion Chemotherapy)
- Immunotherapy
- Targeted Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07436845
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07436845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07436845, "Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07436845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*